Does Seroquel (quetiapine) come in a 12.5mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Availability of Quetiapine 12.5mg Tablets

Yes, quetiapine (Seroquel) is available in a 12.5mg tablet form, which is commonly used as an initial dose for elderly patients or those with hepatic impairment when treating delirium or other psychiatric conditions. 1

Dosage Forms and Strengths

Quetiapine fumarate tablets are available in multiple strengths:

  • 12.5mg (initial dose for elderly patients) 1
  • 25mg (round, pink tablets) 2
  • 50mg (round, white to off-white tablets) 2
  • 100mg (round, yellow tablets) 2
  • 200mg (round, white to off-white tablets) 2
  • 300mg (capsule-shaped, white tablets) 2
  • 400mg (capsule-shaped, yellow tablets) 2

Clinical Applications of Low-Dose Quetiapine

The 12.5mg dose is particularly important in several clinical scenarios:

Elderly Patients

  • Initial dosing: Start with 12.5mg twice daily for elderly patients with delirium or psychiatric conditions 1
  • Titration: Can be gradually increased based on response and tolerability 1
  • Reduced side effects: Lower starting doses help minimize orthostatic hypotension and excessive sedation in older adults 1

Delirium Management

  • Starting dose: 12.5mg is recommended as the initial dose for delirium in medically ill or elderly patients 1
  • Administration: Can be given twice daily (q12h) if scheduled dosing is required 1
  • Advantages: Less likely to cause extrapyramidal symptoms compared to other antipsychotics 1

Hepatic Impairment

  • Dose adjustment: Patients with hepatic impairment should start with lower doses like 12.5mg 1
  • Metabolism: Quetiapine is primarily metabolized through the liver via CYP3A4 enzymes, making dose reduction necessary in hepatic dysfunction 3

Pharmacological Properties

Quetiapine has several properties that make it suitable for use at lower doses:

  • Receptor profile: Antagonist at both serotonin 5-HT2 and dopamine D2 receptors 4
  • Sedative effects: Even at low doses like 12.5mg, can provide sedative effects beneficial in agitation 5
  • Low EPS risk: Maintains placebo-level incidence of extrapyramidal symptoms across its entire dose range 3, 6
  • Prolactin effects: Does not elevate plasma prolactin levels compared to placebo 3

Practical Considerations

  • Titration schedule: When starting with 12.5mg, dose can be gradually increased based on response and tolerability 1
  • Formulation: The 12.5mg tablet is specifically designed for initial dosing in vulnerable populations 1
  • Administration: Oral route only for the tablet formulation 1
  • Monitoring: Regular assessment of response and side effects is important, particularly when starting with low doses 1

Common Pitfalls and Caveats

  • Sedation: Even at 12.5mg, quetiapine can cause significant sedation in some patients 1
  • Orthostatic hypotension: Monitor for dizziness and falls, especially in elderly patients 1
  • Drug interactions: Quetiapine interacts with medications that affect CYP3A4 enzymes 7
  • QTc prolongation: Although less common at lower doses, ECG monitoring may be warranted in patients with cardiac risk factors 1
  • Weight gain: While less pronounced at lower doses, weight monitoring is still recommended 3

The availability of the 12.5mg tablet strength allows for appropriate dosing in vulnerable populations, helping to minimize side effects while still providing therapeutic benefit.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quetiapine fumarate (Seroquel): a new atypical antipsychotic.

Drugs of today (Barcelona, Spain : 1998), 1999

Research

Review of quetiapine and its clinical applications in schizophrenia.

Expert opinion on pharmacotherapy, 2000

Research

Quetiapine: a new atypical antipsychotic.

South Dakota journal of medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.